Evolutionary Genomics Inc

Chart & Performance

D1W1MN

P/E

—

P/S

—

EPS

—

Div Yield, %

—

Shrs. gr., 5y

—

Rev. gr., 5y

Revenues

Net income

-2m

L-31.57%

CFO

-641k

L-59.51%

Profile

Evolutionary Genomics, Inc., together with its subsidiaries, engages in the research and identification of positively selected genes in humans, animals, and commercial crops. The company develops Adapted Traits Platform, a technology platform to identify genes for enhancing crop plant traits, such as yield, sugar content, biomass, drought tolerance, and pest/disease resistance. It serves governmental organizations, non-profit foundations, and commercial entities. Evolutionary Genomics, Inc. was incorporated in 1990 and is based in Castle Rock, Colorado.

URL

http://www.evolgen.com/

IPO date

Mar 03, 2011

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title USD in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY
Title USD in thousands, except ratios and share amounts	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12	2015‑12
Income
Revenues
Cost of revenue	3,036
Unusual Expense (Income)
NOPBT	(3,036)
NOPBT Margin
Operating Taxes	(81)
Tax Rate
NOPAT	(2,955)
Net income	(1,854) -31.57%
Dividends
Dividend yield
Proceeds from repurchase of equity	1,004
BB yield
Debt
Debt current
Long-term debt	3,744
Deferred revenue
Other long-term liabilities	4,024
Net debt	3,167
Cash flow
Cash from operating activities	(641)
CAPEX
Cash from investing activities
Cash from financing activities	1,004
FCF	(2,917)
Balance
Cash	577
Long term investments
Excess cash	577
Stockholders' equity	(17,971)
Invested Capital	20,146
ROIC
ROCE
EV
Common stock shares outstanding	6,459
Price
Market cap
EV
EBITDA	(2,014)
EV/EBITDA
Interest	79
Interest/NOPBT